FEBS Letters
Volume 583, Issue 18 , Pages 3027-3032, 17 September 2009

Lumcorin: A leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration

Edited by Veli-Pekka Lehto

  • Cédric Zeltz

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
    • These two authors contributed equally to this work.
  • ,
  • Stéphane Brézillon

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
    • These two authors contributed equally to this work.
  • ,
  • Corinne Perreau

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
  • ,
  • Laurent Ramont

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
    • CHU de Reims, F-51095 Reims, France
  • ,
  • François-Xavier Maquart

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
    • CHU de Reims, F-51095 Reims, France
  • ,
  • Yanusz Wegrowski

      Affiliations

    • Laboratoire de Biochimie Médicale et de Biologie Moléculaire, CNRS UMR 6237, Université Reims-Champagne-Ardenne, F-51095 Reims, France
    • Corresponding Author InformationCorresponding author. Fax: +33 326 918055.

Received 11 June 2009; received in revised form 31 July 2009; accepted 7 August 2009. published online 17 August 2009.

Abstract 

We previously showed that lumican decreases melanoma progression. The aim of the present study was to determine the active sequence of the lumican core protein responsible for the inhibition of melanoma cell migration. Using different recombinant and synthetic peptides derived from lumican, we localized an active site in the leucine-rich repeat 9 domain of the lumican core protein. We propose the name lumcorin (fragment of lumican core protein) for the active peptide derived from this site. Lumcorin was able to inhibit melanoma cell migration in vitro.

Abbreviations: BSA, bovine serum albumin, ECM, extracellular matrix, LRR, leucine-rich repeat, SLRP, small leucine-rich proteoglycan

Keywords: Lumican, Melanoma, Cell migration, Anti-tumor peptide, Leucine-rich repeat

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00627-9

doi:10.1016/j.febslet.2009.08.012

FEBS Letters
Volume 583, Issue 18 , Pages 3027-3032, 17 September 2009